Skip to main content Skip to main content
VitalDecades logo VitalDecades
Labs and biomarkers

How much does a PSA test cost? Cash prices, and why Medicare's is $0 while private plans may charge

Brian Keller Healthcare Costs & Consumer Research
8 min read

Who made it and how it was checked

By Brian Keller, Healthcare Costs & Consumer Research. Researched and drafted with AI assistance, then edited by the editor named here. Fact-checked by Sarah Whitcomb, Senior Health Editor, . Its sources are listed on this page. No licensed clinician has reviewed it. How we source.

Report an error on this page

Bought alone with fees, a PSA costs $55 at Walk-In Lab, $69 at Labcorp OnDemand and $75 at Quest. Medicare pays a lab $19.31 for a screening PSA and charges men over 50 nothing for it, once every 12 months. Private plans are not required to cover it at no cost, because the USPSTF grades PSA screening C for men 55 to 69, not A or B. Prices read Nov 16, 2026.

On Medicare a PSA costs nothing: Part B pays for a screening PSA once every 12 months for men over 50, at no charge for the test. With private insurance it may not be free, because the federal rule that makes screening free covers only tests the USPSTF grades A or B, and it grades PSA screening C. Read on each seller's page on November 16, 2026, a cash PSA costs $55 at Walk-In Lab ($49 plus a $6.00 order fee), $69 at Labcorp OnDemand and $75 at Quest ($69 plus a $6.00 physician fee).

On this page

PSA prices and preparation, seller by seller

Prices and preparation on each seller's product page, read November 16, 2026. Medicare rates from CMS's 2026 Clinical Laboratory Fee Schedule (October 2026 file). All-in is our arithmetic for the test alone.
WherePriceAdded feeAll-inPreparation the seller lists
Walk-In Lab$49.00$6.00 per order$55.00No ejaculation or strenuous exercise for 72 hours; no biotin for 72 hours; wait six weeks after a prostate biopsy
Quest$69.00$6.00 physician service fee$75.00Avoid ejaculation or vigorous exercise for at least 48 hours
Labcorp OnDemand$69.00None shown$69.00"No special preparation needed."
What Medicare pays a lab$19.31 screening (code G0103); $18.39 total PSA (84153)$9.34 blood draw (code 36415)$28.65 for a screening PSA and drawn/a

Medicare uses its own code, G0103, for the yearly screening PSA and pays slightly more for it than for the same measurement ordered to follow up a symptom or a known problem (84153). That difference is invisible to you on Medicare, because neither costs you anything when covered, but it is why a bill or a statement may show a code you do not recognize. A free PSA, the test sometimes added when the total is between 4 and 10, is a separate measurement that Medicare pays $18.39 for (84154).

Why the price depends on your coverage more than your lab

Medicare. Medicare.gov says Part B covers a PSA blood test once every 12 months for men over 50, starting the day after the 50th birthday, and "you pay nothing for the PSA blood test." A digital rectal exam on the same visit is different: you pay 20% of the Medicare-approved amount after the Part B deductible. Outside the yearly screening, Medicare's national coverage rule for PSA (NCD 190.31) covers the test for urinary symptoms, a prostate cancer diagnosis or monitoring, generally once a year for symptoms unless something changes. On a Medicare Advantage plan, federal rules (42 CFR 422.100(k)) bar cost sharing for in-network Medicare preventive services, which include prostate cancer screening tests other than the rectal exam. If you are 70 or older, our guide to PSA coverage after 70 sets the rule beside the USPSTF's advice.

Private insurance. The Affordable Care Act's no-cost preventive rule covers services the USPSTF grades A or B. The USPSTF's 2018 recommendation, still the final one on November 16, 2026 although its page shows an update in progress, grades PSA screening C for men 55 to 69 ("the decision to undergo periodic prostate-specific antigen (PSA)-based screening for prostate cancer should be an individual one") and D for men 70 and older. PSA screening does not appear on HealthCare.gov's list of no-cost services. Some plans cover it anyway; ask yours, and ask whether your state's law requires coverage. If yours charges the deductible, compare its negotiated rate with the cash prices above.

Decide whether to test before you decide where

A grade C means the benefit is small and depends on the man. The USPSTF summarizes the trade-off in its 2018 statement: screening 1,000 men aged 55 to 69 prevents about 1.3 deaths from prostate cancer over roughly 13 years and about 3 cases of metastatic cancer, against false positives, biopsies and the overdiagnosis of cancers that would never have caused harm. It names Black men and men with a family history as having higher risk. Our prostate cancer screening page sets out how the USPSTF, ACS and the urologists' guideline differ, and normal PSA levels by age explains why there is no official age chart.

Before the draw, and after a high result

The sellers disagree on preparation, so follow the strictest: Walk-In Lab's page says to avoid ejaculation and strenuous exercise for 72 hours, stop biotin at least 72 hours before, and wait at least six weeks after a prostate biopsy; Quest's says to avoid ejaculation or vigorous exercise for at least 48 hours; Labcorp's says no preparation is needed. Waiting costs nothing and avoids a misleading reading. If a result comes back high, the AUA/SUO guideline says to repeat it first, not to go straight to a biopsy: our guide to a PSA between 4 and 10 walks through what follows, and free PSA percentage explains the add-on test.

Who should not buy this test online

Men with urinary symptoms, blood in the urine or semen, bone pain, or a past prostate cancer diagnosis need the test ordered by a clinician who will act on it, and on Medicare those tests are covered under the diagnostic rule. For men 70 and older, the USPSTF recommends against routine screening, so a cash PSA bought "just to check" is the kind of test to discuss first.

What we checked and what we did not

We read each price and preparation note on the seller's product page, the Medicare rates in CMS's October 2026 fee schedule file, Medicare.gov's prostate screening page, NCD 190.31 and the USPSTF recommendation page, all on November 16, 2026. We did not read any insurer's PSA policy. For more prices, see our comparison.

Every price, Medicare rate and coverage rule on this page was checked against the pages listed under Sources on November 16, 2026. We did not buy or take any of these tests.

Frequently asked questions

What does a PSA test cost if I pay cash?

On November 16, 2026: $55 at Walk-In Lab ($49 plus a $6.00 order fee), $69 at Labcorp OnDemand and $75 at Quest ($69 plus a $6.00 fee).

Does Medicare cover a PSA test after 70?

Yes. Medicare.gov's rule is once every 12 months for men over 50 with no upper age, and you pay nothing for the test. The USPSTF recommends against routine screening from 70, so coverage and guidance point different ways; discuss it with your clinician.

Why did my insurance charge me for a PSA?

Most private plans (not grandfathered ones, and in network) must cover USPSTF A and B services without cost sharing. PSA screening is grade C, so a plan may apply your deductible. Medicare is different and charges nothing for the yearly screening PSA.

What should I avoid before a PSA test?

The strictest instruction we found, on Walk-In Lab's page: no ejaculation or strenuous exercise for 72 hours, no biotin for 72 hours, and no PSA within six weeks of a prostate biopsy. Quest's page says 48 hours; Labcorp's lists no preparation.

10 sources

These are the sources this guide cites, with each source's date where it publishes one. How we source.

Read next

How often does Medicare pay for a lipid panel? Every 5 years to screen, more often once you are treated

Medicare pays for a screening lipid panel once every 5 years, counted in months: no screening may be paid in the 59 months after the month of your last one. With a covered diagnosis such as high cholesterol, diabetes or high blood pressure, the test is diagnostic instead, and Medicare's national rule allows a yearly panel and, in the first year of treatment, any one part up to six times. A family history of heart disease or smoking, alone, does not count; a relative with familial hypercholesterolemia or high Lp(a) is on the code list, but a reviewer can still treat the test as screening.

Continue reading

Newsletter

One email a week: what changed, what it costs, what to do. Every item sourced and dated.

You're on the list. Look for your first issue next week.

No spam. Unsubscribe anytime.

Was this helpful?

Your feedback shapes what we cover next.

Thanks for letting us know.

If you found this useful, sign up for our newsletter to get more like this.

Thanks. What was missing?

Optional. We read every response.

Thanks.

We use this to prioritize the next round of edits.

Related Articles

More from Brian Keller

More in Labs and biomarkers